Womastin Injection
Marketer
Khandelwal Laboratories Pvt Ltd
Salt Composition
Carboplatin (150mg)
Overview Womastin Injection
Oncasin is indicated for ovarian and small-cell lung carcinoma. Its mechanism involves inhibiting or retarding cancerous cell proliferation. Administered intravenously under medical supervision, the dosage and frequency are determined by the treating physician based on individual needs and may vary. Strict adherence to the prescribed regimen is crucial; improper use or overdose may lead to severe adverse events. Therapeutic effects might not be apparent for weeks or months; discontinuation should only occur under medical guidance. Common side effects include nausea, emesis, lassitude, and elevated hepatic enzymes. Oncasin can suppress blood cell counts (red and white), potentially increasing infection or bleeding risk. Report fever, pharyngitis, chills, unusual hemorrhage or contusions, and dark urine immediately. Regular blood tests to monitor blood cell counts, cardiac function, liver health, and uric acid levels are necessary. Allergic reactions like dermatitis, pruritus, and dyspnea must be reported. Interaction with other medications is possible; inform your healthcare provider of all concurrent medications. This medication is contraindicated during gestation and lactation. Reliable contraception is essential for both partners throughout the treatment period to prevent conception.
Primary Ingredients of Womastin Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Womastin Injection
Cancers of the ovary and small-cell lung
Major Benefits of Womastin Injection:
This medication will be administered by your physician or registered nurse; please do not self-medicate.
Common Side effects of Womastin Injection:
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Fatigue
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
How to use Womastin Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.
How Womastin Injection works:
Womastin Injection is a cancer therapeutic agent. Its mechanism of action involves disrupting the genetic blueprint (DNA and RNA) within cancerous cells, thereby inhibiting their proliferation and expansion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Womastin Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Womastin Injection during pregnancy is contraindicated due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the inherent dangers. Patient consultation with their physician is advised.
Breast feedingUNSAFE
Administration of Womastin Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Administration of Womastin Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Administering Womastin Injection to individuals with impaired kidney function requires careful consideration. Dosage modification may be necessary. Physician consultation is recommended. Womastin Injection is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is advisable during treatment.
LiverSAFE IF PRESCRIBED
Womastin Injection appears safe for use in individuals with hepatic impairment. Available evidence indicates dose modification may not be necessary. Physician consultation is recommended.
What if you forget to take Womastin Injection :
Omitting a scheduled Womastin Injection requires contacting your physician.
Facts to Know About Womastin Injection
| Label | Value |
|---|---|
| Chemical Classification | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavioral Class | Platinum-based Anticancer Agents |


